Department of Pharmaceutical Biochemistry, Poznan University of Medical Sciences, Rokietnicka 3, 60-806 Poznań, Poland.
Faculty of Chemistry, Adam Mickiewicz University in Poznań, Uniwersytetu Poznańskiego 8, 61-712 Poznań, Poland.
Int J Mol Sci. 2024 Oct 5;25(19):10739. doi: 10.3390/ijms251910739.
Our previous studies demonstrated the modulatory effects of new synthetic thio-chalcone derivatives in dishes on the Nrf2, NF-κB, and STAT3 signaling pathways in colon cancer cells. This study aimed to evaluate the effect of four selected active chalcone thio-derivatives on the NF-κB and STAT3 signaling pathways involved in inflammatory processes and cell proliferation in human liver cancer cells. Cell survival was assessed for cancer (HepG2) and normal (THLE-2) cell lines. Activation of NF-κB and STAT3 signaling pathways and the expression of proteins controlled by these pathways were estimated by Western blot, and qRT-PCR assessed the expression of NF-κB and STAT3 target genes. We also evaluated the impact on the selected kinases responsible for the phosphorylation of the studied transcription factors by MagneticBead-Based Multiplex Immunoassay. Among the thio-derivatives tested, especially derivatives and , there was an impact on cell viability, cell cycle, apoptosis, and activation of NF-κB and STAT3 pathways in hepatocellular carcinoma (HCC), which confirms the possibilities of using them in combinatorial molecular targeted therapy of HCC. The tested synthetic thio-chalcones exhibit anticancer activity by initiating proapoptotic processes in HCC while showing low toxicity to non-cancerous cells. These findings confirm the possibility of using chalcone thio-derivatives in molecularly targeted combination therapy for HCC.
我们之前的研究表明,新型合成硫代查尔酮衍生物在培养皿中对结肠癌细胞中的 Nrf2、NF-κB 和 STAT3 信号通路具有调节作用。本研究旨在评估四种选定的活性查尔酮硫代衍生物对 NF-κB 和 STAT3 信号通路的影响,这些信号通路涉及炎症过程和人肝癌细胞的增殖。评估了癌症(HepG2)和正常(THLE-2)细胞系的细胞存活率。通过 Western blot 评估 NF-κB 和 STAT3 信号通路的激活以及这些通路控制的蛋白质的表达,并通过 qRT-PCR 评估 NF-κB 和 STAT3 靶基因的表达。我们还通过基于磁珠的多重免疫测定评估了对负责研究转录因子磷酸化的选定激酶的影响。在所测试的硫代衍生物中,特别是衍生物 和 ,对肝癌(HCC)中的细胞活力、细胞周期、细胞凋亡以及 NF-κB 和 STAT3 通路的激活有影响,这证实了它们在 HCC 联合分子靶向治疗中的应用可能性。测试的合成硫代查尔酮通过在 HCC 中引发促凋亡过程表现出抗癌活性,同时对非癌细胞的毒性较低。这些发现证实了在 HCC 的分子靶向联合治疗中使用查尔酮硫代衍生物的可能性。